PLx Pharma Inc. just filed a "Statement of acquisition of beneficial ownership", which is also known as a 13D. In the filing, it appears as though PLx Pharma Inc. claims to own 4,414,270 shares. This represents 39.63% of Dipexium Pharmaceuticals, Inc..
Please note that typos are common in SEC filings. Please verify the information reported above before acting on it.
To receive a free e-mail notification whenever Dipexium Pharmaceuticals, Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
Regulation FD - Jan. 8, 2018